San Diego-primarily based Viking Therapeutics marked alone as a serious competitor while in the weight loss drug industry in February following revealing promising info from a mid-stage demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection As well as in March the